News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
199,833 Results
Type
Article (19517)
Company Profile (105)
Press Release (180211)
Section
Business (64179)
Career Advice (818)
Deals (9006)
Drug Delivery (73)
Drug Development (18932)
Employer Resources (139)
FDA (3353)
Job Trends (6011)
News (95715)
Policy (7124)
Tag
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1498)
Academic (2)
Accelerated approval (1)
Adcomms (16)
Allergies (31)
Alliances (17438)
ALS (25)
Alzheimer's disease (527)
Antibody-drug conjugate (ADC) (54)
Approvals (3352)
Artificial intelligence (119)
Autoimmune disease (4)
Automation (7)
Bankruptcy (51)
Best Places to Work (4919)
BIOSECURE Act (11)
Biosimilars (45)
Biotechnology (65)
Bladder cancer (23)
Brain cancer (6)
Breast cancer (82)
Cancer (548)
Cardiovascular disease (53)
Career advice (719)
Career pathing (29)
CAR-T (50)
Cell therapy (139)
Cervical cancer (5)
Clinical research (14335)
Collaboration (334)
Compensation (68)
Complete response letters (7)
COVID-19 (974)
CRISPR (17)
C-suite (100)
Cystic fibrosis (38)
Data (544)
Decentralized trials (1)
Denatured (21)
Depression (15)
Diabetes (63)
Diagnostics (2348)
Digital health (6)
Diversity (7)
Diversity, equity & inclusion (38)
Drug discovery (48)
Drug pricing (46)
Drug shortages (4)
Duchenne muscular dystrophy (32)
Earnings (14711)
Editorial (11)
Employer branding (23)
Employer resources (119)
Events (29770)
Executive appointments (331)
FDA (3629)
Featured Employer (33)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (306)
Gene editing (37)
Generative AI (14)
Gene therapy (92)
GLP-1 (292)
Government (1327)
Guidances (18)
Healthcare (4996)
Huntington's disease (13)
IgA nephropathy (8)
Immunology and inflammation (22)
Indications (4)
Infectious disease (1024)
Inflammatory bowel disease (55)
Inflation Reduction Act (8)
Influenza (12)
Intellectual property (26)
Interviews (115)
IPO (3617)
IRA (18)
Job creations (1306)
Job search strategy (632)
Kidney cancer (1)
Labor market (27)
Layoffs (155)
Leadership (9)
Legal (1182)
Liver cancer (21)
Lung cancer (85)
Lymphoma (48)
Machine learning (1)
Management (42)
Manufacturing (112)
MASH (10)
Medical device (2639)
Medtech (2643)
Mergers & acquisitions (5593)
Metabolic disorders (194)
Multiple sclerosis (31)
NASH (9)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (690)
NextGen: Class of 2025 (2134)
Non-profit (1689)
Northern California (700)
Now hiring (35)
Obesity (123)
Opinion (92)
Ovarian cancer (21)
Pain (27)
Pancreatic cancer (12)
Parkinson's disease (40)
Partnered (10)
Patents (44)
Patient recruitment (19)
Peanut (24)
People (27003)
Pharmaceutical (25)
Pharmacy benefit managers (1)
Phase I (4214)
Phase II (5932)
Phase III (5714)
Pipeline (224)
Podcasts (28)
Policy (46)
Postmarket research (571)
Preclinical (2386)
Press Release (61)
Prostate cancer (23)
Psychedelics (18)
Radiopharmaceuticals (63)
Rare diseases (106)
Real estate (2533)
Recruiting (54)
Regulatory (5126)
Reports (34)
Research institute (1267)
Resumes & cover letters (106)
RNA editing (1)
RSV (22)
Schizophrenia (21)
Series A (63)
Series B (35)
Service/supplier (8)
Sickle cell disease (21)
Southern California (497)
Special edition (8)
Sponsored (13)
Startups (1992)
State (1)
Stomach cancer (6)
Supply chain (19)
The Weekly (7)
United States (6079)
Vaccines (193)
Venture capitalists (25)
Webinars (9)
Weight loss (88)
Women's health (12)
Worklife (14)
Date
Today (31)
Last 7 days (179)
Last 30 days (882)
Last 365 days (10929)
2025 (2098)
2024 (11501)
2023 (13113)
2022 (15769)
2021 (17826)
2020 (16445)
2019 (15150)
2018 (10956)
2017 (10442)
2016 (10329)
2015 (11003)
2014 (8093)
2013 (7011)
2012 (7435)
2011 (7600)
2010 (7094)
Location
Africa (323)
Alabama (21)
Alaska (4)
Arizona (60)
Arkansas (4)
Asia (11248)
Australia (1963)
California (1495)
Canada (565)
China (119)
Colorado (87)
Connecticut (62)
Delaware (67)
Europe (29021)
Florida (226)
Georgia (51)
Hawaii (1)
Idaho (12)
Illinois (119)
India (14)
Indiana (132)
Iowa (4)
Japan (58)
Kansas (27)
Kentucky (7)
Louisiana (3)
Maine (6)
Maryland (185)
Massachusetts (1261)
Michigan (86)
Minnesota (106)
Mississippi (1)
Missouri (28)
Montana (4)
Nebraska (9)
Nevada (10)
New Hampshire (12)
New Jersey (501)
New Mexico (16)
New York (576)
North Carolina (302)
North Dakota (7)
Northern California (700)
Ohio (62)
Oklahoma (5)
Oregon (15)
Pennsylvania (244)
Puerto Rico (2)
Rhode Island (7)
South America (391)
South Carolina (5)
Southern California (497)
Tennessee (28)
Texas (197)
Utah (38)
Virginia (38)
Washington D.C. (22)
Washington State (127)
Wisconsin (27)
199,833 Results for "epic sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Congress Re-Introduces EPIC Act to Remove IRA’s ‘Pill Penalty’
While many industry players and observers have high hopes for the EPIC Act, some say budgetary headwinds could make it difficult for the current administration to make meaningful repeals or amendments to the IRA.
February 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
February 20, 2025
·
4 min read
Press Releases
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
February 10, 2025
·
3 min read
Press Releases
Baylor Genetics to Integrate with Epic Aura to Enhance Efficiency and Deliver Genetic Testing Results to Hospitals and Health Systems
January 14, 2025
·
3 min read
Biotech Bay
Epic Bio to Present IND-Enabling Data Package for EPI-321 at FSHD International Research Congress
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, announced its participation in the upcoming FSHD International Research Congress being held June 13-14, 2024, in Denver, Colo.
June 7, 2024
·
2 min read
Business
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
GeneDx, a leader in delivering improved health outcomes through genomic insights, announced that it is expanding access to its rapid whole genome sequencing services in neonatal intensive care units with leading health systems through a new collaboration with Epic.
June 10, 2024
·
4 min read
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Canaccord Genuity Genetic Medicine for Generalists
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced that Amber Salzman, Ph.D., chief executive officer, participated in a fireside chat at the Canaccord Genuity - Genetic Medicine for Generalists Fireside Chat today.
April 10, 2024
·
1 min read
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Cantor Virtual Muscular Dystrophy Symposium
Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman, Ph.D., chief executive officer, will participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium at 9:40 a.m. PT, Tuesday, April 2, 2024.
April 1, 2024
·
1 min read
Biotech Bay
Epic Bio to Present at the Upcoming BMO Life Sciences Private Company Showcase
Epic Bio today announced that Amber Salzman, Ph.D., chief executive officer, will present at the BMO Fall Private Company Showcase being held Thursday, October 12, 2023, New York, NY.
October 5, 2023
·
1 min read
Biotech Bay
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman, Ph.D., chief executive officer, will present at the Charles River Cell & Gene Therapy Summit at 2:00 p.m. PT, Tuesday, March 19, 2024, in South San Francisco, Calif.
March 13, 2024
·
1 min read
1 of 19,984
Next
